Patents Assigned to Roche TCRC Inc.
  • DOSING FOR TREATMENT WITH ANTI-CD20/ANTI-CD3 BISPECIFIC ANTIBODY
    Publication number: 20220372156
    Abstract: The present invention relates to methods of treating a B-cell proliferative disorder by administering an anti-CD20/anti-CD3 bispecific antibody, and methods for reduction of adverse effects in response to the administration of the anti-CD20/anti-CD3 bispecific antibody. The present invention further relates to combination treatment methods of treating a B-cell proliferative disorder.
    Type: Application
    Filed: April 29, 2022
    Publication date: November 24, 2022
    Applicants: Hoffmann-La Roche Inc., Roche TCRC Inc.
    Inventors: Katharina LECHNER, Linda LUNDBERG, Thomas Francis MOORE, Peter MORCOS, Martin WEISSER, Marina BACAC, Martin BARRETT, Axel BOEHNKE, David CARLILE, Nassim DJEBLI